Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide
Jen‐Yu Hsu(National Yang Ming Chiao Tung University), Chien‐Ching Hung(National Taiwan University), Sui‐Yuan Chang(National Taiwan University of Science and Technology), Yu‐Shan Huang(Capital Medical University), Hsin‐Yun Sun(National Taiwan University Hospital), Yu‐Chung Chuang(National Taiwan University Hospital), Ling-Ya Chen(National Taiwan University Hospital), Yi‐Ching Su(National Taiwan University Hospital), Wen‐Chun Liu(National Taiwan University Hospital)
Cited by 10
Related Papers
Animal models for COVID-19
|Nature|2020|877
Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure
|Journal of Bacteriology|1987|512
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics
|Nature Biomedical Engineering|2021|433
Prolonged virus shedding even after seroconversion in a patient with COVID-19
|Journal of Infection|2020|302